While the development of a novel therapeutic agent from SQDG against COVID-19 is complex, discovering a compound that selectively inhibits SARS-CoV-2 replication is highly significant.
← all excerpts
Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro.
1
—
—